Health AI Central
Share:
Peer-Reviewed Publication
Nat Biotechnol2019;37(10):1112-1115.October 1, 2019Letter

Database shares that transform research subjects into partners.

Robert Kain1, Scott Kahn2, Debora Thompson2, David Lewis2, David Barker3, Carlos Bustamante3,4,5, Christian Cabou3, Alexander Casdin3,6, Francisco Garcia3,7, Jason Paragas3, Aristides Patrinos3, Aditya Rajagopal3,8, Sharon F Terry3,9, Ashley Van Zeeland3,10, Ed Yu3,11, Yaniv Erlich3,12, Dawn Barry13
1LunaPBC, San Diego, CA, USA. bob@lunadna.com.
2LunaPBC, San Diego, CA, USA.
3Advisor to LunaPBC, San Diego, CA, USA.
4F-Prime Capital, Cambridge, MA, USA.
5CDB Consulting, Redwood City, CA, USA.
6Reneo Capital Management LP, New York, NY, USA.
7GSWC Group, Rancho Santa Fe, CA, USA.
8ChromaCode, Carlsbad, CA, USA.
9Genetic Alliance, Washington, DC, USA.
10Illumina, San Diego, CA, USA.
11Vascular Cures, Redwood City, CA, USA.
12Department of Computer Science, Fu Foundation School of Engineering, Columbia University, New York, NY, USA.
13LunaPBC, San Diego, CA, USA. dawn@lunadna.com.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.